Drugs Made In America Acquisition Corp是一家總部位於美國的公司,從事行業營運。公司總部位於佛羅里達州勞德代爾堡。該公司在2025年1月28日首次公開募股(IPO)。Drugs Made In America Acquisition Corp 是一家空白支票公司。該公司註冊為免稅公司,目的是與一個或多個企業進行合併、股份交換、資產收購、股份購買、資本重組、重新組織或其他類似的業務合併。儘管公司計劃專注於在製藥行業中尋找業務合併目標,但其尋找潛在目標企業的努力不限定於特定行業或地理區域。
DMAAU stock price ended at $10.55 on 星期四, after rising 0.00%
On the latest trading day Jan 29, 2026, the stock price of DMAAU rose by 0.00%, climbing from $10.55 to $10.55. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $10.55 and a high of $10.55. Notably, trading volume dropped by 322 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 608 shares were traded, equating to a market value of approximately $353.6M.